# A Study of GD007 (Human iPSC-Exosome Liquid Dressing) for Safety and Dose-Finding in Moderate-Severe Intrauterine Adhesions

> **NCT07101484** · NA · ENROLLING_BY_INVITATION · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 29 (estimated)

## Conditions studied

- Moderate-Severe Intrauterine Adhesions

## Interventions

- **DRUG:** GD007 Low-dose drug group
- **DRUG:** GD007 Mid-dose drug group
- **DRUG:** GD007 High-dose drug group
- **DRUG:** GD007 Blank Control drug Group

## Key facts

- **NCT ID:** NCT07101484
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-05-04
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07101484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07101484, "A Study of GD007 (Human iPSC-Exosome Liquid Dressing) for Safety and Dose-Finding in Moderate-Severe Intrauterine Adhesions". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT07101484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*